Takeaway
GNE genotype explains around 20% of variability in the onset of the disease and has a significant influence on the rate of ambulation loss in people with GNE myopathy.
Why this matters ?
Associations between GNE genotype and disease phenotype could have important implications for patient management and the design of future clinical trials.